Prognostic role of derived neutrophil-to-lymphocyte ratio in surgical triple-negative breast cancer

References

• KohlerBAShermanRLHowladerNAnnual Report to the Nation on the Status of Cancer, 1975–2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and stateJ Natl Cancer Inst20151076djv04825825511
   PubMed Web of Science ®Google Scholar
• BrewsterAMChavez-MacgregorMBrownPEpidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestryLancet Oncol20141513e625e63425456381
   PubMed Web of Science ®Google Scholar
• BoschAErolesPZaragozaRViñaJRLluchATriple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of researchCancer Treat Rev201036320621520060649
   PubMed Web of Science ®Google Scholar
• SparanoJAGrayRJMakowerDFProspective validation of a 21-gene expression assay in breast cancerN Engl J Med2015373212005201426412349
   PubMed Web of Science ®Google Scholar
• AliHRProvenzanoEDawsonSJAssociation between CD8+ T-cell infiltration and breast cancer survival in 12,439 patientsAnn Oncol20142581536154324915873
   PubMed Web of Science ®Google Scholar
• MuenstSSoysalSDGaoFObermannECOertliDGillandersWEThe presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancerBreast Cancer Res Treat2013139366767623756627
   PubMed Web of Science ®Google Scholar
• MahmoudSMPaishECPoweDGAn evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancerBreast Cancer Res Treat201112719910820556505
   PubMed Web of Science ®Google Scholar
• LiuCHuangZWangQUsefulness of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in hormone-receptor-negative breast cancerOnco Targets Ther201694653466027536129
   PubMed Web of Science ®Google Scholar
• KohCHBhoo-PathyNNgKLUtility of pre-treatment neu-trophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancerBr J Cancer2015113115015826022929
   PubMed Web of Science ®Google Scholar
• YaoMLiuYJinHPrognostic value of preoperative inflammatory markers in Chinese patients with breast cancerOnco Targets Ther201471743175225328407
   PubMed Web of Science ®Google Scholar
• NohHEommMHanAUsefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patientsJ Breast Cancer2013161555923593082
   PubMed Web of Science ®Google Scholar
• YamagishiTFujimotoNNishiHPrognostic significance of the lymphocyte-to-monocyte ratio in patients with malignant pleural mesotheliomaLung Cancer201590111111726259877
   PubMed Web of Science ®Google Scholar
• SpolveratoGMaqsoodHKimYNeutrophil-lymphocyte and platelet-lymphocyte ratio in patients after resection for hepatopancre-atico-biliary malignanciesJ Surg Oncol2015111786887425865111
   PubMed Web of Science ®Google Scholar
• LiuCWuSMengXPredictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapyOncotarget2017826434274343828624781
   PubMedGoogle Scholar
• PengBWangYHLiuYMMaLXPrognostic significance of the neutrophil to lymphocyte ratio in patients with non-small cell lung cancer: a systemic review and meta-analysisInt J Clin Exp Med2015833098310626064198
   PubMed Web of Science ®Google Scholar
• FerrucciPFGandiniSBattagliaABaseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patientsBr J Cancer2015112121904191026010413
   PubMed Web of Science ®Google Scholar
• PinatoDJShinerRJSecklMJStebbingJSharmaRMauriFAPrognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancerBr J Cancer201411081930193524667648
   PubMed Web of Science ®Google Scholar
• BerardiRRinaldiSSantoniMPrognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapyOncotarget2016718269162692427029035
   PubMedGoogle Scholar
• LolliCBassoUDerosaLSystemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinibOncotarget2016734545645457127409344
   PubMedGoogle Scholar
• SantoniMde GiorgiUIacovelliRPre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinomaBr J Cancer201310971755175924008663
   PubMed Web of Science ®Google Scholar
• SongSLiCLiSGaoHLanXXueYDerived neutrophil to lymphocyte ratio and monocyte to lymphocyte ratio may be better biomarkers for predicting overall survival of patients with advanced gastric cancerOnco Targets Ther2017103145315428706446
   PubMed Web of Science ®Google Scholar
• FerrucciPFAsciertoPAPigozzoJBaseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumabAnn Oncol201627473273826802161
   PubMed Web of Science ®Google Scholar
• GrenaderTNashSPlotkinYDerived neutrophil lymphocyte ratio may predict benefit from cisplatin in the advanced biliary cancer: the ABC-02 and BT-22 studiesAnn Oncol20152691910191626037798
   PubMed Web of Science ®Google Scholar
• DengQHeBLiuXPrognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive modelJ Transl Med2015136625885254
   PubMed Web of Science ®Google Scholar
• AbsengerGSzkanderaJPichlerMA derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patientsBr J Cancer2013109239540023820252
   PubMed Web of Science ®Google Scholar
• DalpiazOLuefTSelesMCritical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinomaBr J Cancer20171161859027907929
   PubMed Web of Science ®Google Scholar
• RussoAFranchinaTRicciardiGRRBaseline neutrophilia, derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or DocetaxelJ Cell Physiol20182331063376343
   PubMed Web of Science ®Google Scholar
• DiakosCICharlesKAMcmillanDCClarkeSJCancer-related inflammation and treatment effectivenessLancet Oncol20141511e493e50325281468
   PubMed Web of Science ®Google Scholar
• de LarcoJEWuertzBRFurchtLTThe potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8Clin Cancer Res200410154895490015297389
   PubMed Web of Science ®Google Scholar
• GrivennikovSIGretenFRKarinMImmunity, inflammation, and cancerCell2010140688389920303878
   PubMed Web of Science ®Google Scholar
• TaoHMimuraYAoeKPrognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cellsLung Cancer20127519510121719142
   PubMed Web of Science ®Google Scholar
• ShaoSRischEBurnerDLuLMinevBMaWIFNγ enhances cytotoxic efficiency of the cytotoxic T lymphocytes against human glioma cellsInt Immunopharmacol20174715916528410529
   PubMed Web of Science ®Google Scholar
• LuLBaiYWangZElevated T cell activation score is associated with improved survival of breast cancerBreast Cancer Res Treat2017164368969628488141
   PubMed Web of Science ®Google Scholar
• Arias-PulidoHCimino-MathewsAChaherNThe combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcomeBreast Cancer Res Treat2018171227328229858752
   PubMed Web of Science ®Google Scholar
• CoxSHurtCGrenaderTMukherjeeSBridgewaterJCrosbyTThe prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapyRadiother Oncol2017125115415928893415
   PubMed Web of Science ®Google Scholar
• Krenn-PilkoSLangsenlehnerUStojakovicTThe elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patientsTumour Biol201637136136826219894
   PubMedGoogle Scholar
• DiricanAKucukzeybekBBAlacaciogluADo the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?Int J Clin Oncol2015201708124532163
   PubMed Web of Science ®Google Scholar
• YingHQDengQWHeBSThe prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patientsMed Oncol2014311230525355641
   PubMed Web of Science ®Google Scholar
• PistelliMde LisaMBallatoreZPre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patientsBMC Cancer20151519525884918
   PubMed Web of Science ®Google Scholar
• ProctorMJMcMillanDCMorrisonDSFletcherCDHorganPGClarkeSJA derived neutrophil to lymphocyte ratio predicts survival in patients with cancerBr J Cancer2012107469569922828611
   PubMed Web of Science ®Google Scholar
• HattarKFranzKLudwigMInteractions between neutrophils and non-small cell lung cancer cells: enhancement of tumor proliferation and inflammatory mediator synthesisCancer Immunol Immunother201463121297130625186613
   PubMed Web of Science ®Google Scholar
• HoughtonAMRzymkiewiczDMJiHNeutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growthNat Med201016221922320081861
   PubMed Web of Science ®Google Scholar